MiddleBrook expanding promotion of Moxatag through IncreaseRx program
WESTLAKE, Texas MiddleBrook Pharmaceuticals plans to promote its extended-release antibiotic by expanding a Web-based marketing program, the drug maker announced Wednesday.
IncreaseRx is a virtual sales-contract organization that gives healthcare professionals access to electronic sampling, learning and education tools. The company has entered an agreement with DoctorDirectory.com, its promotion partner for Moxatag (amoxicillin), and plans to use Web-based educational and promotional tactics to reach prescribers with sales and marketing messages for the drug.
“Under this expanded IncreaseRx program, physicians who previously received Moxatag samples and information from MiddleBrook field sales representatives will be able to request samples and receive important product information electronically,” MiddleBrook acting president and CEO Dave Becker said. “We will be able to reach more than 150,000 physicians across the nation through the expanded IncreaseRx program for Moxatag.”
NCPA: Drug manufacturers should pay rebates in DoD’s Tricare program
ALEXANDRIA, Va. The National Community Pharmacists Association expressed support of the U.S. Department of Defense’s efforts to collect the same manufacturer rebates for the Tricare retail pharmacy program that are applicable to prescriptions filled at Tricare mail-order pharmacies and military treatment facilities.
Tricare beneficiaries may lose face-to-face interaction with their pharmacists if such reimbursements are not provided to them, NCPA said. Currently, prescriptions used in the Tricare retail pharmacy network are subject to federal ceiling prices under law. NCPA believes that the DoD shouldn’t be denied billions of dollars in rebates from drug manufacturers, or make Tricare members solely use mail-order prescriptions.
“The Department of Defense provides prescription drug benefits to active duty, reserve, and retired military families and wants to reduce cost, maintain access and produce the best health outcomes possible,” said Bruce Roberts, NCPA EVP and CEO. “However, drug manufacturers undercut those goals by not paying their fair share of federal ceiling prices. Studies indicate pharmacists are critical to patients in impacting medication adherence, but if drug manufacturers continue to only pay rebates for mail order prescriptions then that won’t occur. The Department of Defense should hold the drug manufacturers accountable for all their financial obligations.
“Without changes, the choice Tricare beneficiaries take for granted about where to get their prescription drugs might fall by the wayside as increased use of mail order would become an unfortunate, but possible reality,” added Roberts.
Report: Lilly drugs stolen out of warehouse
HARTFORD, Conn. Burglars stole $70 million worth of prescription drugs from an Eli Lilly warehouse, according to published reports.
The Associated Press reported Tuesday that the burglars disabled the alarm, climbed the wall, cut a hole in the roof and rappelled inside the warehouse, in Enfield, Conn. Drugs stolen included anti-depressants and anti-psychotics, though there were no painkillers in the warehouse. Law enforcement officials told AP that they stole enough to fill a tractor-trailer.
The FBI has been called to investigate, AP reported.